drugset / Trial / NCT01262677
Once-A-Day Pregabalin For Partial Seizures
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Approximately 30% percent of subjects with partial seizures are refractory to treatment with single or combination antiepileptic drugs. The present study will compare the efficacy of two different dosages of pregabalin CR dosed once daily as compared to placebo, when used as adjunctive therapy in subjects requiring adjunctive therapy for partial onset epilepsy, using a randomized, parallel group design.
Timeline
- Start
- 2011-02-17
- Primary completion
- 2012-07-31
- Completion
- 2012-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 165 mg | — |
| Subject | Pregabalin | Small molecule | 330 mg | — |